Europe — EMA

Palonosetrón Qilu (Palonosetron)

Palonosetron, the active ingredient in Palonosetrón Qilu, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Palonosetron

Request sourcing

Pack/s

What is Palonosetron?

Palonosetron, the active ingredient in Palonosetrón Qilu, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult patients. GNH USA supplies Palonosetrón Qilu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres worldwide.

GNH USA supplies Palonosetrón Qilu as a licensed, GDP‑compliant international pharmaceutical ...

What is Palonosetron used for?

Palonosetron is ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →